MétaCan
Menu
Back to cohort
Record W4308461274 · doi:10.1016/j.jcjd.2022.11.003

Recent Developments in Islet Biology: A Review With Patient Perspectives

2022· review· en· W4308461274 on OpenAlexafffundvenue
Lahari Basu, Vriti Bhagat, Ma. Enrica Angela Ching, Anna Di Giandomenico, Sylvie Dostie, Dana Greenberg, Marley Greenberg, Jiwon Hahm, N. Zoe Hilton, Krista Lamb, Emelien M Jentz, Matt Larsen, Cassandra A.A. Locatelli, MaryAnn Maloney, Christine MacGibbon, Farida Mersali, Christina Marie Mulchandani, Adhiyat Najam, Ishnoor Singh, Tom Weisz, Jordan Wong, Peter Senior, Jennifer L. Estall, Erin E. Mulvihill, Robert A. Screaton

Bibliographic record

VenueCanadian Journal of Diabetes · 2022
Typereview
Languageen
FieldMedicine
TopicPancreatic function and diabetes
Canadian institutionsSunnybrook Health Science CentreUniversité de MontréalMontreal Clinical Research InstituteUniversity of AlbertaDiabetes CanadaAlliance for Canadian Health Outcomes Research in DiabetesUniversity of OttawaWestern UniversityUniversity of TorontoBC Children's HospitalToronto General HospitalUniversity of WaterlooCarleton University
FundersCanadian Institutes of Health ResearchDiabetes Action CanadaDiabetes CanadaCanadian Diabetes Association
KeywordsType 2 diabetesMedicineType 1 diabetesDiabetes mellitusContext (archaeology)IsletBioinformaticsDiseaseInsulinBiologyEndocrinologyInternal medicine

Abstract

fetched live from OpenAlex

Navigating the coronavirus disease-2019 (COVID-19, now COVID) pandemic has required resilience and creativity worldwide. Despite early challenges to productivity, more than 2,000 peer-reviewed articles on islet biology were published in 2021. Herein, we highlight noteworthy advances in islet research between January 2021 and April 2022, focussing on 5 areas. First, we discuss new insights into the role of glucokinase, mitogen-activated protein kinase-kinase/extracellular signal-regulated kinase and mitochondrial function on insulin secretion from the pancreatic β cell, provided by new genetically modified mouse models and live imaging. We then discuss a new connection between lipid handling and improved insulin secretion in the context of glucotoxicity, focussing on fatty acid-binding protein 4 and fetuin-A. Advances in high-throughput "omic" analysis evolved to where one can generate more finely tuned genetic and molecular profiles within broad classifications of type 1 diabetes and type 2 diabetes. Next, we highlight breakthroughs in diabetes treatment using stem cell-derived β cells and innovative strategies to improve islet survival posttransplantation. Last, we update our understanding of the impact of severe acute respiratory syndrome-coronavirus-2 infection on pancreatic islet function and discuss current evidence regarding proposed links between COVID and new-onset diabetes. We address these breakthroughs in 2 settings: one for a scientific audience and the other for the public, particularly those living with or affected by diabetes. Bridging biomedical research in diabetes to the community living with or affected by diabetes, our partners living with type 1 diabetes or type 2 diabetes also provide their perspectives on these latest advances in islet biology.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.006
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0030.004
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0060.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.292
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2022
Admission routes3
Has abstractno

Explore more

Same venueCanadian Journal of DiabetesSame topicPancreatic function and diabetesFrench-language works237,207